CapseraDrug names and class vocabulary
Read selected label passages and connect ten named medicines with class terms. Name endings are memory cues, not a universal classification rule.
Practice
Read selected label passages and connect ten named medicines with class terms. Name endings are memory cues, not a universal classification rule.
How the calculation works
Read selected label passages and connect ten named medicines with class terms. Name endings are memory cues, not a universal classification rule.
For learning, not clinical decisions. US label and brand information; always consult the current source.
Name endings by drug class
ACE inhibitors
-pril
Angiotensin II receptor blockers
-sartan
Beta-adrenergic blockers
-olol
HMG-CoA reductase inhibitors
-statin
Proton pump inhibitors
-prazole
SGLT2 inhibitors
-gliflozin
DPP-4 inhibitors
-gliptin
GLP-1 receptor agonists
-glutide
5-HT1B/1D receptor agonists
-triptan
Direct factor Xa inhibitors
-xaban
Medicines by name ending
Reviewed name endings: 10 · Medicines: 32
| -pril — Lisinopril, Benazepril, Enalapril, Ramipril |
| -sartan — Losartan, Valsartan, Irbesartan, Telmisartan |
| -olol — Metoprolol, Atenolol, Propranolol, Nebivolol, Bisoprolol |
| -statin — Atorvastatin, Rosuvastatin, Simvastatin, Pravastatin, Lovastatin |
| -prazole — Omeprazole, Pantoprazole, Esomeprazole magnesium |
| -gliflozin — Empagliflozin, Dapagliflozin |
| -gliptin — Sitagliptin, Linagliptin |
| -glutide — Semaglutide, Dulaglutide, Liraglutide |
| -triptan — Sumatriptan, Rizatriptan |
| -xaban — Apixaban, Rivaroxaban |
Name endings with their medicines and pronunciation
-pril · ACE inhibitors: Lisinopril (ly-SIN-oh-pril), Benazepril (ben-AY-ze-pril), Enalapril (e-NAL-a-pril), Ramipril (RA-mi-pril)
-sartan · Angiotensin II receptor blockers: Losartan (loe-SAR-tan), Valsartan (val-SAR-tan), Irbesartan (ir-be-SAR-tan), Telmisartan (tel-mi-SAR-tan)
-olol · Beta-adrenergic blockers: Metoprolol (me-TOE-proe-lol), Atenolol (a-TEN-oh-lol), Propranolol (proe-PRAN-oh-lol), Nebivolol (ne-BIV-oh-lol), Bisoprolol (bis-OH-proe-lol)
-statin · HMG-CoA reductase inhibitors: Atorvastatin (a-TOR-va-sta-tin), Rosuvastatin (roe-SOO-va-sta-tin), Simvastatin (SIM-va-sta-tin), Pravastatin (PRA-va-sta-tin), Lovastatin (LOE-va-sta-tin)
-prazole · Proton pump inhibitors: Omeprazole (oh-MEP-ra-zole), Pantoprazole (pan-TOE-pra-zole), Esomeprazole magnesium (es-oh-MEP-ra-zole)
-gliflozin · SGLT2 inhibitors: Empagliflozin (em-pa-gli-FLOE-zin), Dapagliflozin (dap-a-gli-FLOE-zin)
-gliptin · DPP-4 inhibitors: Sitagliptin (sit-a-GLIP-tin), Linagliptin (lin-a-GLIP-tin)
-glutide · GLP-1 receptor agonists: Semaglutide (sem-a-GLOO-tide), Dulaglutide (doo-la-GLOO-tide), Liraglutide (LIR-a-GLOO-tide)
-triptan · 5-HT1B/1D receptor agonists: Sumatriptan (soo-ma-TRIP-tan), Rizatriptan (rye-za-TRIP-tan)
-xaban · Direct factor Xa inhibitors: Apixaban (a-PIX-a-ban), Rivaroxaban (riv-a-ROX-a-ban)
Practice
Try it here, without an account.
Brand and generic drug quiz
Connect a familiar brand name to its generic name. Each answer comes from the study deck, with a link back to the card.
02Generic to brand name quiz
Practice the other direction: find a source-listed US brand for a generic drug.
03Drug class practice
Build connections between generic names and pharmacologic classes.
04Drug uses practice
Review the uses listed on each study card. This is a learning exercise, not a treatment recommendation.
05Mechanism of action quiz
Match a source-based mechanism summary to the drug it describes.
06Your drug study plan
Set a date and a daily study window. Get a simple first-pass target, then use Capsera for due reviews and progress.
07Drug names and class vocabulary
Read selected label passages and connect ten named medicines with class terms. Name endings are memory cues, not a universal classification rule.
08Read boxed-warning passages
Practice locating warning topics in twelve short, source-linked US label excerpts. Open the full warning for its context.
09Read adverse-effect passages
Identify terms in twelve selected US label excerpts. This is source-reading practice, not a complete list of a medicine’s effects.